Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable and accrued other liabilities | (3,322) | (7,911) |
| Net cash used in operating activities | (32,438) | (32,533) |
| Cash flows from investing activities: | ||
| Acquisitions of property and equipment | (2) | (387) |
| Purchases of investments | (77,973) | (64,663) |
| Maturities of investments | 60,000 | 87,500 |
| Net cash (used in) provided by investing activities | (17,975) | 22,450 |
| Cash flows from financing activities: |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s capex?
- Oric Pharmaceuticals, Inc. (ORIC) reported capex of $2K in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s capex changed year-over-year?
- Oric Pharmaceuticals, Inc.'s capex decreased by 99.5% year-over-year, from $387K to $2K.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s capex?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s capex has grown at a -6.7% compound annual growth rate (CAGR), from $939K to $712K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Oric Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude